![Sung Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sung Lee
Directeur Financier/CFO chez
CYTOKINETICS, INCORPORATED
Fortune : 6 M $ au 30/06/2026
Profil
Sung H.
Lee is currently Lead Independent Director at Tango Therapeutics, Inc. since 2026 and Chief Financial Officer & Executive Vice President at Cytokinetics, Inc. since 2024.
Former positions include Vice President-Investor Relations at Gilead Sciences, Inc. from 2016 to 2019, Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2019 to 2021, Chief Financial Officer at MorphoSys AG from 2021 to 2023, and Chief Financial Officer & Executive Vice President at Vir Biotechnology, Inc. from 2023 to 2024.
Education includes graduate studies at the University of Southern California and undergraduate studies at the University of California, Irvine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/07/2026 | 63 221 ( 0,05 % ) | 5 M $ | 30/06/2026 | |
TANGO THERAPEUTICS, INC. 0,02 % | 05/06/2026 | 22 870 ( 0,02 % ) | 714 916 $ | 30/06/2026 |
Postes actifs de Sung Lee
| Sociétés | Poste | Début |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Directeur Financier/CFO | 08/05/2024 |
| TANGO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/01/2026 |
Anciens postes connus de Sung Lee
| Sociétés | Poste | Fin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Directeur Financier/CFO | 03/05/2024 |
| MORPHOSYS AG | Directeur Financier/CFO | 17/03/2023 |
| SANGAMO THERAPEUTICS, INC. | Directeur Financier/CFO | 01/02/2021 |
| GILEAD SCIENCES, INC. | Investor Relations Contact | 31/10/2019 |
Formation de Sung Lee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
